Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_837_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Second Edition Clinical Decision Making
- •Acknowledgments
- •Contents
- •Editors and Contributors
- •Editors
- •Contributors
- •Refer to Algorithm in Fig. 1.1
- •Conclusion
- •Suggested Reading
- •1: Anorectal Examination
- •Suggested Reading
- •3: Physiologic Testing
- •Refer to Algorithm in Fig. 3.3
- •Suggested Reading
- •Refer to Algorithm in Fig. 4.1
- •Single Center Studies
- •Special Considerations
- •Low Rectal or Coloanal Anastomosis
- •Multi-center Studies
- •Suggested Reading
- •Summary
- •Suggested Reading
- •Introduction
- •Refer to Algorithm in Fig. 6.1
- •Minimally Invasive Colorectal Surgery
- •Intraoperative Fluid Administration
- •Analgesia
- •Venous Thromboembolism Prophylaxis
- •Surgical Site Infection Prevention
- •Postoperative Analgesia
- •Intravenous Fluid Management
- •Early Oral Feeding
- •Early Ambulation
- •Conclusion
- •Suggested Reading
- •Refer to Algorithm in Fig. 7.1
- •Refer to Algorithm in Fig. 7.2
- •Melena Caused by Upper Gastrointestinal Bleeding
- •Hematochezia Caused by Anorectal Bleeding
- •Severe Hematochezia Causing Hemodynamic Instability
- •Suggested Reading
- •Suggested Reading
- •Suggested Reading
- •10: Anal Conditions: Anal Fissure/Recurrent Anal Fissure
- •Suggested Reading
- •Suggested Reading
- •12: Anorectal Abscess
- •Suggested Reading
- •13: Anal Conditions: Fistula-in-Ano
- •Suggested Reading
- •14: Anal Conditions: Rectovaginal Fistula
- •Refer to Algorithm in Fig. 14.1
- •Background
- •Etiology
- •Evaluation
- •Treatment
- •Ileoanal Pouch-Vaginal Fistulas
- •Vaginal Approaches
- •Conclusion
- •Suggested Reading
- •15: Anal Conditions: Anorectal Crohn’s Disease—Fistula
- •Introduction
- •Conclusion
- •Suggested Reading
- •Suggested Reading
- •Suggested Reading
- •18: Anal Conditions: External Hemorrhoids
- •Introduction
- •Refer to Algorithm in Fig. 18.4
- •Suggested Reading
- •Refer to Algorithm in Fig. 19.1
- •D. Hair Removal
- •Suggested Reading
- •20: Anal Conditions: Pruritus Ani
- •Suggested Reading
- •21: Anal Conditions: Hidradenitis Suppurativa
- •Suggested Reading
- •22: Anal Conditions: Anorectal Trauma
- •Suggested Reading
- •23: Anal Conditions: STDs
- •Refer to Algorithm in Fig. 23.1
- •Anal Conditions: Sexually Transmitted Diseases
- •Suggested Reading
- •24: Anal Considerations: Fournier’s Gangrene
- •Refer to Algorithm in Fig. 24.1
- •Suggested Reading
- •25: Non-healing Perineal Wounds
- •Suggested Reading
- •26: Anal Intraepithelial Neoplasms
- •Diagnoses
- •Suggested Reading
- •27: Anal Conditions: Anal Margin Tumors
- •Suggested Reading
- •28: Invasive Anal Canal Neoplasia
- •Suggested Reading
- •29: Pelvic Floor Conditions: Rectal Prolapse/Recurrence
- •Suggested Reading
- •30: Pelvic Floor Conditions: Rectal Intussusception
- •Suggested Reading
- •31: Pelvic Outlet Obstruction
- •Suggested Reading
- •32: Pelvic Floor Conditions: Biofeedback
- •Background
- •Pelvic Floor Dysfunction
- •Biofeedback Therapy
- •Suggested Reading
- •33: Pelvic Floor Conditions: Fecal Incontinence
- •Fiber Supplementation
- •Medications
- •Biofeedback
- •End-to-End Sphincteroplasty
- •Tibial Nerve Stimulation
- •Graciloplasty
- •Gluteoplasty
- •∗Other Therapies
- •Injectables
- •RF Remodeling
- •Conclusion
- •Suggested Reading
- •34: Pelvic Floor Conditions: Diarrhea
- •Refer to Algorithm in Fig. 34.1
- •Suggested Reading
- •35: Chronic Constipation
- •Introduction
- •Diagnosis
- •Management
- •Suggested Reading
- •36: Retrorectal Tumors
- •Evaluation
- •Risk Assessment
- •Pathology: Four Tissue Types
- •Treatment
- •Suggested Reading
- •37: Rectal Cancer: Local Therapy
- •Suggested Reading
- •38: Rectal Conditions: Rectal Cancer—Proctectomy
- •Suggested Reading
- •39: Rectal Conditions: Rectal Cancer—Adjuvant and Neoadjuvant Therapy
- •Refer to Algorithm in Fig. 39.1
- •Suggested Reading
- •40: Rectal Conditions: Stage IV Rectal Cancer
- •Introduction
- •Refer to Algorithm in Fig. 40.1
- •Suggested Reading
- •Refer to Algorithm in Fig. 41.1
- •Suggested Reading
- •42: Rectal Conditions: Rectal Cancer—Postoperative Surveillance
- •Suggested Reading
- •43: Recurrent Rectal Cancer
- •Introduction
- •Refer to Algorithm in Fig. 43.2
- •A–C.
- •Carbon-Ion Radiation (CIRT)
- •Conclusion
- •Suggested Reading
- •44: Locally Advanced Rectal Cancer
- •Suggested Reading
- •45: Colonic: Diverticulitis
- •Refer to Algorithm in Fig. 45.1
- •Suggested Reading
- •46: Colonic Conditions: Large Bowel Obstruction
- •Suggested Reading
- •47: Colonic Conditions: Volvulus
- •Refer to Algorithm in Fig. 47.1
- •Introduction
- •Suggested Reading
- •48: Colonic Stricture
- •Suggested Reading
- •49: Acute Colonic Pseudo-Obstruction (ACPO): Ogilvie’s Syndrome
- •Suggested Reading
- •50: Colonic Conditions: Irritable Bowel Syndrome (IBS)
- •Introduction
- •Suggested Reading
- •51: Colorectal Trauma
- •Suggested Reading
- •52: Endometriosis
- •Suggested Reading
- •53: Colonic Conditions: Ulcerative Colitis
- •Conclusions
- •Suggested Reading
- •54: Colonic Conditions: Indeterminate Colitis
- •Suggested Reading
- •55: Colonic Conditions: Toxic Colitis
- •Medical Management
- •Risk Assessment
- •Surgical Management
- •Suggested Reading
- •56: Crohn’s Colitis
- •Suggested Reading
- •57: Ischemic Colitis
- •Suggested Reading
- •58: Colonic Conditions: Infectious Colitis
- •Suggested Reading
- •59: Colonic Conditions: Benign Colonic Neoplasia
- •Suggested Reading
- •60: Familial Adenomatous Polyposis
- •Suggested Reading
- •61: Colonic Conditions: Lynch Syndrome
- •Suspected Lynch Syndrome
- •Lynch Syndrome Diagnosis Without Clinical Symptoms or Phenotype
- •Suggested Reading
- •62: Malignant Colon Polyps
- •Suggested Reading
- •63: Colonic Conditions: Adenomatous Polyps
- •Suggested Reading
- •64: Colon Cancer Surgical Therapy
- •Suggested Reading
- •65: Colonic Conditions: Locally Advanced Colon Cancer
- •Conclusion
- •Suggested Reading
- •66: Recurrent Colon Cancer
- •Suggested Reading
- •67: Appendiceal Neoplasms

Non-healing Perineal Wounds
JoshuaH.Wolf andMartinNewman
25
Refer toAlgorithm inFig. 25.1
A. Patient history should be directed toward
eliciting the various risk factors that have
either prevented or arrested progression
towards complete healing. Some of these factors may be subject to modication, including tobacco abuse, alcohol addiction,
nutritional deciency, and obesity.
Inammation is a normal and important
phase of wound healing, and medications
that attenuate the inammatory process, such
as steroids, immunosuppressive or anti-metabolic drugs may have a profound effect on
wound progression. Modiable risks should
be reduced or eliminated. Patients should be
counseled regarding the importance of smoking cessation and weight loss, and total nutritional support should be considered in cases
of chronic malnutrition.
B. Certain non-modiable attributes can also
predispose patients to NHPW. The largest
study of perineal wounds after APR to date,
by Althumari et al. (reference listed in
J. H. Wolf (*)
Department of Surgery, Sinai Hospital, LifeBridge
Health, Baltimore, MD, USA
e-mail: wolfj3@ccf.org
M. Newman
Department ofPlastic andReconstructive Surgery,
Cleveland Clinic Florida, Weston, FL, USA
“Further Reading”), found that wound complications were associated with African
American race, ASA class >4, smoking history, obesity, and chronic obstructive pulmonary disease (COPD). Other comorbid
conditions that have been associated with
poor wound healing include diabetes, inammatory bowel disease (IBD), immunodeciency and vasculopathy. While these
comorbidities are not generally reversible,
they should be aggressively controlled with
medical treatment and specialty
consultation.
C. Cellular injury due to radionecrosis, burns or
pressure sores will signicantly impede healing, and may ultimately lead to ulceration
and necrosis. Radiation injury in the form of
radionecrosis is unique in that the injury may
be both delayed (6weeks after exposure) and
then progressive over time. Pressure ulceration in the perineum occurs in bedridden or
paraplegic patients, and may rst compromise the tissue immediately overlying the
ischium or sacrum. In many cases of cellular
injury, tissue is scarred or malperfused in the
areas surrounding the wound itself. This may
limit the success of local rotational aps and
skin grafts. Non-viable tissue should be
widely debrided and reconstructed with tissue from outside the zone of injury, i.e. a
regional or free ap.
© Springer Nature Switzerland AG 2020
S. R. Steele etal. (eds.), Clinical Decision Making in Colorectal Surgery,
https://doi.org/10.1007/978-3-319-65942-8_25
195

196
Fig. 25.1 Algorithm for management of non-healing perineal wounds
J. H. Wolf and M. Newman
D. Perineal surgery often overlaps with one or
several of the above risk factors. For example, abdominoperineal resection (APR) for
rectal cancer may involve a radiated eld
from neoadjuvant treatment. Perianal surgery or APR in the setting of Crohn’s disease
can lead to scarring in an already malnourished patient on immunosuppressive therapy. The surgeon may wish to consider these
additional factors when planning an operative approach. For example, it may be preferable to delay proctectomy and perineal
closure in patients with Crohn’s or mucosal
ulcerative colitis and perform a staged procedure. If appropriate, intersphincteric dissection may help reduce wound size and
improve closure integrity. Surgical positioning should be carefully considered as well,
as some data have suggested higher rates of
wound failure for patients positioned in
lithotomy.
E. Infection must be denitely controlled to
allow for wound closure. Fournier’s gangrene is a polymicrobial necrotizing infection requiring aggressive debridement, broad
spectrum antibiotic coverage and frequent
dressing changes with Betadine or saline
soaked gauze. Repeat debridement is often
required to remove all nonviable tissue.
Other infectious causes for NHPW include
pilonidal disease and hidradenitis suppurativa, and management for both of these
problems can be found in other chapters of
this book.
F. NHPWs may also harbor malignancies in
two distinct scenarios: (1) If the perineal
wound is related to an already known malignancy, for example, an APR that was performed for Nigro-resistant or recurrent
squamous cell carcinoma, then any delayed
healing should prompt a high index of suspicion for recurrent disease. (2) Malignant
transformation can occur in the absence of
cancer history, arising de novo in chronically
inamed tissue. A rm plaque or fungating
mass in a non-healing wound bed should
raise suspicion and biopsy should be considered. However, the specic steps for diagnosis and treatment for soft tissue tumors of the
perineum are beyond the scope of this
chapter.
G. Physical examination of NHPW involves
careful assessment of the following wound
features:
(a) Dimensions.
(b) Structures involved (e.g., bone, muscle,
soft tissue and skin).
(c) Anatomic position.

25 Non-healing Perineal Wounds
197
(d) Presence or absence of infection.
(e) Quality of surrounding tissue.
(f) Involvement of urogynecological or neu-
rologic structures.
Full evaluation requires a digital rectal
examination in men and women, a vaginal
and bimanual examination in women.
There are often obstacles that prevent this
from being done in the ofce, such as
patient body habitus, pain and tenderness,
need for multiple biopsies, or patient anxiety. In these scenarios the examination may
be performed in the operating room under
anesthesia at the discretion of the operating
surgeon.
H. Imaging is not always critical, but it may
often be helpful to exclude underlying processes such as abscess, stulae, or bony
involvement. Studies may include pelvic
computed tomography (CT), magnetic resonance imaging (MRI), or stulagram. Bone
scans can be used to assist with evaluation of
osteomyelitis. However, bone biopsy is often
required to conrm the diagnosis.
I. Macrodebridement and microdebridement
are two options for cleaning wounds in
preparation for further healing and eventual
closure. Macrodebridement involves surgical excision of nonviable or infected tissue
back to healthy-appearing bleeding edges,
and removal of any brinous debris.
Depending on the degree of involvement,
this can be accomplished at the bedside or
in the operating room under anesthesia.
Microdebridement refers to the use of regular wet-to-dry dressing changes, which help
remove brin and stimulate growth of fresh
granulation tissue.
J. Fecal diversion may be appropriate in cases
in which microdebridement or secondary
healing will likely be impeded by contamination. Examples include complex perianal
stulae (watering-can perineum), perineal
wounds in patients with baseline fecal incontinence, or large or complex wounds immediately adjacent to the sphincter complex.
K. Urology/gynecology consultation can be
helpful when stulae to these respective
organ systems have been demonstrated on
physical examination or imaging.
L. Based on a variety of clinical, psychological
and social factors a course of healing by secondary intention may prove the best options in
some cases, for example, if the patient is a poor
surgical candidate. Healing by secondary intension may also be the appropriate choice for
wounds that are too large for primary closure,
or that contain persistent contamination requiring serial macrodebridement. It should be
noted, however, that healing by secondary
intention can be a very lengthy and labor intensive/resource fueled endeavor. Thus, a variety
of adjuncts have been developed to expedite the
process. Moist wound dressings include alginate, silicone or polyurethane foam or beads, or
hydrocolloid dressings. There are mixed data
regarding superior healing for any of these
techniques over gauze dressings, though foam
dressings have been shown to improve patient
comfort. Antimicrobial applications such as
Betadine, Medihoney, petroleum or silver sulfasalazine are used to theoretically help reduce
contamination. Negative- pressure wound
dressings (NPWD) have been credited by many
as helpful in promoting granulation and eventual re- epithelialization. The data on hyperbaric
oxygen therapy is mixed but leans towards having an overall benecial effect on wound
healing in certain cases. Bioelectric treatments
and stem cell-based therapies remain
experimental.
M. Direct primary closure for NHPWs can be
attempted once the wound is clear of infection and necrosis. Re-approximation is an
option if there are healthy appearing skin
edges that approximate without tension.
N. For deeper, more complex NHPWs that are
not amenable to direct re-approximation, ap
closures can be considered. Flaps can be
broadly categorized by proximity to the
wound, and the strengths and weaknesses of
each subtype are reviewed in Table25.1.

198
Table 25.1 Categorization of ap subtypes
Flap type Vascular pedicle Advantage Disadvantage
Local Random blood supply Avoids donor site
Regional
Gracilis Medial femoral
Gluteus
maximus
Rectus
abdominis
Omental Right or left
Free
Anterolateral
thigh
circumex artery
Inferior or superior
gluteal artery
Deep inferior epigastric
artery
gastroepiploic artery
Descending branch of
lateral femoral circumex
artery
morbidities that accompany
regional and free aps
Simple to design and
execute
Minimal functional
morbidity, avoids abdominal
incision
Minimal functional
morbidity, avoids abdominal
incision
Large tissue bulk Risk of incisional hernia at donor site,
Large tissue bulk Laparotomy or laparoscopic harvest
Minimal functional
morbidity, avoids abdominal
incision
Broad application restricted by limited
bulk and need for excellent tissue
quality surrounding wound
Small skin paddle and limited tissue
bulk
Limited arc of rotation
obliteration of potential future stoma
site
required, no skin paddle
Only moderate bulk
Signicant anatomic variability
Time consuming and technically
demanding
J. H. Wolf and M. Newman
(a) Local aps generally refer to the transpo-
sition—in one form or another—of adjacent skin and subcutaneous tissue into
the wound bed and are based on—most
often—a random blood supply. A rotational ap is a commonly employed
example. Local aps are usually acceptable if the surrounding tissue is well perfused, not scarred or brotic, and has not
been exposed to radiation. Tissue must
be easily transferable without tension.
This type of ap differs signicantly
from the others that will be discussed
because the vascular pedicle is not specically isolated.
(b) Regional aps are usually larger seg-
ments of tissue mobilized from their
native tissue beds and imported to ll
the defect in question. These aps may
include a combination of skin, subcutaneous tissue, fascia and muscle.
However, pure muscle or simple fasciocutaneous aps often are adequate.
Regional aps often involve careful
preservation of the vascular pedicle.
Thus, the native vessels supplying these
aps must have adequate length to reach
the wound. Common regional ap
options include gracilis, gluteus maximus, rectus abdominis myocutaneous
aps or omental pedicle aps.
Mobilization, transfer and nal positioning of both a gracilis ap and vertical
rectus abdominis myocutaneous ap
(VRAM) are shown in Figs. 25.2 and
25.3, respectively.
(c) Free ap closure represents the top rung
of the reconstructive ladder. Although
free aps are more technically demanding than the other options listed and are
associated with signicant donor site
morbidity, they are uniquely capable of
lling defects when all other options
have been exhausted, An common example of such is the anterolateral thigh fasciocutaneous ap.

ab
cd
ab
25 Non-healing Perineal Wounds
199
Fig. 25.2 Gracilis muscle ap harvest and transposition.
The gracilis muscle is identied and mobilized through
two incisions along medial thigh with care to preserve its
vascular pedicle (a and b). It is then tunneled subcutane-
c
ously and transposed into the perineal defect (c). Final
incisions are shown at case conclusion (d). (Courtesy of
Dr. Steven D.Wexner)
Fig. 25.3 Vertical rectus abdominis myocutaneous ap
(VRAM). The rectus abdominis muscle is mobilized with
a skin paddle (a) and brought into the perineal wound (b).
The regional ap is perfused by the inferior epigastric
artery. Final incisions and drain placement are shown at
case conclusion (c). (Courtesy of Dr. Steven D.Wexner)

200
J. H. Wolf and M. Newman
Suggested Reading
Althumairi A, Canner JK, Gearhart S, Safar B, Fang S,
Wick EC, Efron JE.Risk factors for wound complications after abdominoperineal excision: analysis of
ACS NSQIP database. Color Dis. 2016;18:O260–6.
Boatent J, Catanzano O.Advanced therapeutic dressings
for effective wound healing—a review. J Pharm Sci.
2015;104:3653–80.
Genua JC, Vivas DA.Management of nonhealing perineal
wounds. Clin Colon Rectal Surg. 2007;20:322–8.
Kamrava A, Mahmoud NN. Prevention and management
of nonhealing perineal wounds. Clin Colon Rectal
Surg. 2013;26:106–11.
Moon HK, Caminer D, Boyd JB. Chapter 42: unhealed
perineal wounds. In: Wexner SD, Vernava A, editors. Clinical decision-making in colorectal surgery.
Philadelphia: Lippincott and Williams; 1995.
Vermeulen H, Ubbink DT, Goossens VRD, Legemate
DA.Systematic review of dressings and topical agents
for surgical wounds healing by secondary intention.
British J Surgery. 2005;92:665–72.

Anal Intraepithelial Neoplasms
AlexisR.Harvey andScottR.Steele
26
Refer toAlgorithm in Fig.26.1
A. Carcinoma of the anus is a relatively rare
cancer, with an annual incidence less than
2/100,000, and the incidence has been rising
at a rate of 2.2% each year, due largely to
improved survival of persons with HIV.The
National Cancer Institute estimates 8080
new cases and 1080 deaths will occur in
2016. Incidence is highest among white
females and black men (2.1/100,000) and
median age at presentation is 61years. Fiveyear mortality is 66.4% overall but 80.7% if
discovered while still conned to the primary site. According to the Centers for
Disease Control, more than 90% of these
malignancies are associated with human
papillomavirus (HPV), primarily serotypes
16 and 18. Similar to HPV-related cervical
cancers, anal cancer is preceded by a protracted pre-malignant dysplastic phase
called anal intraepithelial neoplasia (AIN),
supporting a role for routine screening in
high-risk populations and early, targeted
treatment and/or active surveillance when
dysplasia is recognized. Vaccination against
A. R. Harvey
School ofMedicine, Case Western Reserve
University, Cleveland, OH, USA
S. R. Steele (*)
Department ofColorectal Surgery, Cleveland Clinic,
Cleveland, OH, USA
oncogenic strains of HPV can prevent anal
cancer. Vaccination is most effective when
administered before risk of HPV exposure,
but there is evidence that post-exposure vaccination is also protective.
Risk factors for anal intraepithelial neoplasms include HPV infection, HIV seropositivity, history of anoreceptive intercourse,
increased number of lifetime sexual partners,
history of other HPV-related neoplasia (e.g.,
cervical intraepithelial neoplasia, cervical
cancer), immunosuppression due to transplantation, and smoking. We recommend vaccination and annual routine screening by anal
Pap smear (refer to section B in algorithm) in
this population. A thorough patient history is
critical to elucidate relevant risk factors.
HIV+ patients must be compliant with
HAART to benet from HPV vaccination.
Routine screening is not recommended for
persons not at increased risk but may be indicated based on clinical suspicion of AIN or
anal cancer. In this population, normal cytology does not require additional follow up.
B. The anal Papanicolaou (Pap) smear is per-
formed in the same manner as a standard
cervical Pap smear. Advise the patient to
refrain from anoreceptive intercourse and
intra-anal enema or other preparation prior
to examination. A small brush or Dacron
swab moistened with water is inserted into
the anus 2–3 in beyond the internal anal
© Springer Nature Switzerland AG 2020
S. R. Steele etal. (eds.), Clinical Decision Making in Colorectal Surgery,
https://doi.org/10.1007/978-3-319-65942-8_26
201

202
A. R. Harvey and S. R. Steele
Fig. 26.1 Algorithm for treatment of anal intraepithelial neoplasms
sphincter and dentate line. Using rm lateral
pressure, continuously rotate the swab 360°
while withdrawing slowly from the anus.
Sample collection should take 15–30 s,
being sure to sample the entire anal canal,
including the non-keratinized mucosa, the
anorectal junction, and the keratinized anal
verge. Fix and package the sample for transport according to the test manufacturer’s
specications. Do not use a cotton swab or
lubrication as they will interfere with the
slide mount and interpretation. Deliver to a
trained pathologist for interpretation. As
part of a thorough physical examination, a
digital rectal exam (DRE) should be performed to detect frank lesions.
Normal ndings in high-risk individuals
with no visually-apparent lesion or concerning symptoms (anal itching, bleeding, and/or
pain) are referred for repeat screening in
1 year. Normal ndings in persons not at
increased risk do not require additional follow- up. Atypical results, regardless of risk
factors, are referred for high resolution anoscopy (refer to section C in algorithm).
C. High-resolution anoscopy is used to visual
dysplasia invivo. Acetic acid (3%) turns acetowhite when applied to dysplastic tissue.
Using an anoscope to access the anal canal, a
gauze-wrapped cotton swabbed dipped in
3% acetic acid is placed in the canal and the
anoscope is removed. After 1 min, the anoscope is reinserted and the cotton swab gently removed. A colposcope is used to magnify
and thoroughly inspect the anal canal. If no
lesion is found, the patient should be reexamined periodically (refer to section D in
the algorithm). Dysplastic tissue that has
turned white can be further investigated by
applying Lugol’s solution. Lesions that do
not take up Lugol’s solution are more likely
to be a high-grade dysplasia. Reactive tissue

26 Anal Intraepithelial Neoplasms
203
should be biopsied for diagnosis (refer to
section E in algorithm). As part of a thorough
physical examination, a digital rectal exam
should be performed to detect frank lesions.
D. Active surveillance simply means serial
examinations with high resolution anoscopy
at regular periods to discover new lesions in
at-risk individuals; to monitor changes in
slow-growing lesions; or to catch recurrence
in treated individuals. HPV is notoriously
persistent because the virus can lie dormant
in seemingly uninvolved tissue or be reintroduced in an individual that has fully
cleared their infection. Furthermore, infection with one strain does not confer immunity
against other strains.
• Atypical cytology (section B) suggests
exposure and/or increased risk even if a
frank lesion is not apparent (section C).
These patients should be re-examined by
DRE and HRA every 3–6months for sev-
eral years (varies by institutional prac-
tices) prior to going back to the screening
regimen once stable and free of disease.
• Medically managed non-cancerous lesions
require monitoring every 3–6 months to
assess response to treatment or progression
to a higher-grade lesion or to cancer.
Monitoring should continue as long as dys-
plasia is appreciated, even if it is respond-
ing to treatment. Persistent or progressive
lesions may require ablation. If lesion
regresses, monitoring should continue
every 3–6months for recurrence as above.
• High-grade lesions treated with ablation
require active surveillance every
3–6months for recurrence.
• Cancers treated with chemoradiation or
surgical resection require active surveillance
every 3–6months to look for persistence or
recurrence in accordance with NCCN and
ASCRS clinical practice guidelines.
E. Lesions discovered during HRA can be
immediately biopsied using forceps and a
scalpel. The small sample should be formalin
xed and sent to a pathologist for evaluation.
Diagnoses
F. Condylomata are epidermal growths caused
by one of more than 30 distinct strains of
HPV, though 90% are caused by strains 6 and
11. These strains are very unlikely to cause
cancer, but history of condylomata is associated with exposure to other, some oncogenic,
strains of HPV and potentially the development of cancer. All persons presenting with
HPV condylomata can be treated with a topical agent or targeted destruction. They should
also be offered vaccination to protect against
future re-infection. High-risk individuals
should continue annual screening for
neoplasia.
Topical treatments include 5% imiquimod
cream and 5% 5-uorouracil (FU) cream.
Imiquimod is an immune modulator that acts
to stimulate the body’s natural immune system against the HPV infection. The cream is
applied at bedtime three times per week for
up to 16weeks and washed off with soap and
water the next morning. Imiquimod is not
always curative, and may cause side effects—
redness, irritation, induration, or ulceration—
that are sometimes bothersome enough to
affect patient compliance. Topical 5-FU
blocks DNA replication, preventing a cell
population from continuing to grow. It is used
for 9–16 weeks with very good response
rates. Targeted tissue destruction (ablation)
using HRA-guided infrared coagulation may
also be used. There is a high risk of recurrence with all of these treatments, further
supporting the recommendation that highrisk individuals continue annual screening.
G. Anal intraepithelial neoplasia I (AIN I) is low-
grade dysplasia and is believed to be caused
by a transient, self-limited HPV infection that
has a low chance of progressing to cancer.
There have been several categorization
schemes dened to characterize anal neoplasia. AIN I is synonymous with the early cytological designation of low-grade squamous
intraepithelial lesion (LSIL) and the WHO’s

204
A. R. Harvey and S. R. Steele
classication of low-grade anal intraepithelial
neoplasia (LGAIN). Despite the adoption of
screening practices, AIN I is often discovered
incidentally during an unrelated procedure.
Note that AIN and cervical intraepithelial neoplasia often occur simultaneously, so women
diagnosed should also be referred to a gynecologist for a thorough examination.
AIN I is unlikely to progress to malignancy, especially in immunocompetent
patients and those not engaged in high risk
behaviors; although the chance of progression is higher in immunosuppressed patients.
These slow-growing lesions are best treated
with topical agents and followed closely in
active surveillance. Because of the risk of
recurrence or re-infection, vaccination should
be offered to these high-risk patients.
In persons who are not at increased risk,
topical therapy and active surveillance (i.e.,
“watch and wait”) may be used or they may
opt for targeted ablation and then follow up
with an annual screening Pap smear.
H. Anal intraepithelial neoplasia II and III, inter-
mediate- and high-grade neoplasia, are considered together. These designations are
synonymous with high-grade squamous
intraepithelial lesion and high-grade anal
intraepithelial neoplasia. These lesions tend
to be more persistent, more aggressive, and
more likely to progress to malignancy.
Treatment of them is only slightly more
aggressive, however. High-risk individuals
may choose the topical or targeted ablation
with active surveillance. Those not at
increased risk should be treated with ablation
and also followed in active surveillance.
Recurrence or persistence and progression
are not uncommon in this group, so continued
surveillance is critical.
I. Anal cancers may be of several histologic
types, including cloacogenic, basaloid, epidermoid, and mucoepidermoid, but the majority are squamous cell carcinomas. While they
together represent less than 2% of all colorectal malignancies, incidence is increasing and
morbidity is high.
Anal cancers develop as a slow-growing
mass within the anal canal as far as the anorec-
tal junction, at the anal verge, or in the perianal region. Symptoms are present in 50% of
cases and may include pain, bleeding, pruritus, irritation; 20% of cases are asymptomatic
at presentation. Half of anal cancer patients
present with localized disease, one-third with
regional nodal involvement, and 10–15% with
distant metastases. Most commonly involved
lymph nodes are the inguino-femoral group
and may cause groin pain.
A cancer diagnosis should prompt a complete physical exam including visual inspection, digital rectal exam, and lymph node
investigation to conrm the disease and
determine stage. The digital rectal exam can
reveal location, xation, and/or invasion.
Palpate the groin for lymphadenopathy; perform a ne needle biopsy on suspicious
nodes. Anoscopic or sigmoidoscopic biopsy
may facilitate staging and enable assessment
for concomitant colorectal neoplasms. A CT
of the chest, abdomen, or pelvis should be
ordered to evaluate lymph node involvement
and regional spread. Consider a PET/CT if
distant metastases are suspected. Stage
according to the American Joint Committee
on Cancer (AJCC) small cell cancer (SCC)
staging criteria.
Local disease (conned to the primary
site) and regional disease (lymph node
involvement) are both treated with standard
CRT and then followed with active surveillance as described below. Standard CRT
includes mitomycin C (MMC) and 5-uorouracil (5-FU) plus gamma radiation of the
pelvic basin from L5/S1 to the perianal skin,
including pelvic and inguino- femoral lymph
nodes in the eld.
Regional disease requires that the radiation
eld be expanded to include the area around
he involved lymph node. Studies have shown
that CRT has equivalent outcomes to the previous standard treatment—abdominoperineal
resection (APR)—while preserving the
sphincter function for the patient. Radiation
alone is not recommended.
Cancer located at the anal margins present
with bleeding, pruritus, and an ulcerated mass
with rolled, everted edges. They are staged
Соседние файлы в папке Библиотека им академика М.И. Перельмана
